Evidence map›Paper›PMID 36050504›Full record

ArticleScientific reports2022

Clinical and radiological evaluation of maxillofacial and otorhinolaryngological manifestations of Hansen's disease.

Rachel Bertolani do Espírito Santo, Rachel Azevedo Serafim, Rafael Maffei Loureiro, Dâmaris Versiani Caldeira Gonçalves, Daniel Vaccaro Sumi, Ricardo Andrade Fernandes de Mello, Simon M Collin, Patrícia D Deps

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rachel Bertolani do Espírito SantoPostgraduate Programme in Infectious Diseases, Universidade Federal do Espírito Santo, Vitoria, Espírito Santo, Brazil.
Rachel Azevedo SerafimPostgraduate Programme in Infectious Diseases, Universidade Federal do Espírito Santo, Vitoria, Espírito Santo, Brazil.
Rafael Maffei LoureiroImaging Department, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Dâmaris Versiani Caldeira GonçalvesPostgraduate Programme in Infectious Diseases, Universidade Federal do Espírito Santo, Vitoria, Espírito Santo, Brazil.
Daniel Vaccaro SumiImaging Department, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Ricardo Andrade Fernandes de MelloDepartment of Internal Medicine, Federal University of Espírito Santo, Vitoria, Espírito Santo, Brazil.
Simon M CollinPostgraduate Programme in Infectious Diseases, Universidade Federal do Espírito Santo, Vitoria, Espírito Santo, Brazil.
Patrícia D DepsPostgraduate Programme in Infectious Diseases, Universidade Federal do Espírito Santo, Vitoria, Espírito Santo, Brazil. patricia.deps@ufes.br.
Universidade Federal do Espírito Santo · BRHospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To characterize maxillofacial, otorhinolaryngological and oral manifestations of Hansen's disease (HD), we conducted a cross-sectional study in 21 current patients attending the Unidade Básica de Saúde de Jardim América, Espírito Santo, Brazil and 16 former patients resident at Pedro Fontes Hospital using data from computed tomography imaging, rhinoscopy, and oroscopy. Maxillofacial characteristics were compared with 37 controls. Differences in bone alterations across the three groups were determined mainly by severe resorption/atrophy being more frequent in former HD patients, with severe resorption/atrophy of the anterior alveolar process of maxilla in 50.0% (8/16) of former patients, 28.6% (6/21) of current patients and 10.8% (4/37) of controls and of nasal bones and aperture in 31.3% (5/16) of former patients compared with 0/21 current patients and two controls. There were no substantial differences in otorhinolaryngological and oroscopic findings between the two patient groups. HD patients had more tooth loss than the age-matched control group. Maxillofacial, otorhinolaryngological and oroscopic finding scores were strongly correlated only in current HD patients. Correlation between otorhinolaryngological and maxillofacial scores suggests that protocols for HD patient assessment and follow-up could include otorhinolaryngological evaluation, with radiological imaging where necessary, subject to replication of our findings in a larger study.

Indexed as

LeprosyAtrophyBrazilCross-Sectional StudiesHumans

Identifiers

PMID36050504
PMCPMC9436959
OpenAlexW4294167216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.